132 results
8-K
EX-10.1
CPMV
Mosaic ImmunoEngineering Inc.
29 Apr 24
Regulation FD Disclosure
8:00am
party’s satisfaction with its due diligence review of the other party’s business and operations.
The negotiation of mutually acceptable definitive
DEF 14C
bsbw322zlys7 qlrto
25 Jun 21
Information statement
12:05pm
PRE 14C
dffvzbc9uva8tex
15 Jun 21
Preliminary information
4:00pm
10-KT
EX-10.9
mdkjx3na4k
2 Mar 21
Annual report (with FYE transition)
1:44pm
10-KT
z7r2w108 8euzxqw
2 Mar 21
Annual report (with FYE transition)
1:44pm
10-KT
EX-10.8
lvqo3 8n2cif7u3r
2 Mar 21
Annual report (with FYE transition)
1:44pm